Cytovene (ganciclovir) - Roche
Prevymis (letermovir) - Merck (MSD)
Evaluation of the use of Ganciclovir and Letermovir in special patients and optimization of clinical dosing regimens (ChiCTR) - Jun 5, 2025 - P=N/A | N=150 | Completed | Sponsor: the First Affiliated Hospital of Xian Jiaotong University; the First Affiliated Hospital of Xian Jiaotong University 
New trial • Cytomegalovirus Infection • Infectious Disease
https://www.chictr.org.cn/showproj.html?proj=257536
 
Jun 5, 2025
 
Prev Next